Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC34105102538;102539;102540 chr2:178534302;178534301;178534300chr2:179399029;179399028;179399027
N2AB3246497615;97616;97617 chr2:178534302;178534301;178534300chr2:179399029;179399028;179399027
N2A3153794834;94835;94836 chr2:178534302;178534301;178534300chr2:179399029;179399028;179399027
N2B2504075343;75344;75345 chr2:178534302;178534301;178534300chr2:179399029;179399028;179399027
Novex-12516575718;75719;75720 chr2:178534302;178534301;178534300chr2:179399029;179399028;179399027
Novex-22523275919;75920;75921 chr2:178534302;178534301;178534300chr2:179399029;179399028;179399027
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: V
  • RefSeq wild type transcript codon: GTT
  • RefSeq wild type template codon: CAA
  • Domain: Kinase-1
  • Domain position: 293
  • Q(SASA): 0.36
  • Predicted PPI site: I

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
V/D rs747672013 -0.063 None N None 0.28 0.695266575812 gnomAD-2.1.1 4.02E-06 None None None None I None 0 2.9E-05 None 0 0 None 0 None 0 0 0
V/D rs747672013 -0.063 None N None 0.28 0.695266575812 gnomAD-4.0.0 1.59135E-06 None None None None I None 0 2.28634E-05 None 0 0 None 0 0 0 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
V/A 0.5187 ambiguous 0.3978 ambiguous -0.487 Destabilizing None None None None N 0.446475136 None None I
V/C 0.9379 likely_pathogenic 0.9162 pathogenic -0.943 Destabilizing None None None None None None None None I
V/D 0.9461 likely_pathogenic 0.8697 pathogenic -0.37 Destabilizing None None None None N 0.448382077 None None I
V/E 0.8983 likely_pathogenic 0.785 pathogenic -0.47 Destabilizing None None None None None None None None I
V/F 0.6791 likely_pathogenic 0.521 ambiguous -0.678 Destabilizing None None None None N 0.447688644 None None I
V/G 0.7478 likely_pathogenic 0.6234 pathogenic -0.592 Destabilizing None None None None N 0.448208719 None None I
V/H 0.9682 likely_pathogenic 0.928 pathogenic -0.028 Destabilizing None None None None None None None None I
V/I 0.1464 likely_benign 0.1437 benign -0.349 Destabilizing None None None None N 0.42632915 None None I
V/K 0.9305 likely_pathogenic 0.8443 pathogenic -0.539 Destabilizing None None None None None None None None I
V/L 0.6035 likely_pathogenic 0.5263 ambiguous -0.349 Destabilizing None None None None N 0.445088269 None None I
V/M 0.5498 ambiguous 0.4653 ambiguous -0.619 Destabilizing None None None None None None None None I
V/N 0.881 likely_pathogenic 0.7705 pathogenic -0.421 Destabilizing None None None None None None None None I
V/P 0.9116 likely_pathogenic 0.8294 pathogenic -0.364 Destabilizing None None None None None None None None I
V/Q 0.9024 likely_pathogenic 0.8114 pathogenic -0.618 Destabilizing None None None None None None None None I
V/R 0.8992 likely_pathogenic 0.7836 pathogenic -0.029 Destabilizing None None None None None None None None I
V/S 0.7678 likely_pathogenic 0.62 pathogenic -0.772 Destabilizing None None None None None None None None I
V/T 0.5756 likely_pathogenic 0.4487 ambiguous -0.769 Destabilizing None None None None None None None None I
V/W 0.9878 likely_pathogenic 0.9724 pathogenic -0.729 Destabilizing None None None None None None None None I
V/Y 0.9464 likely_pathogenic 0.885 pathogenic -0.463 Destabilizing None None None None None None None None I

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.